Martin Olin is a Danish businessperson who has been the head of 6 different companies. Presently, Mr. Olin holds the position of Chairman of AcouSort AB, Chief Executive Officer of BerGenBio ASA and Managing Director at Nordic Eye Management ApS. Mr. Olin is also on the board of Cessatech A.
In his past career he held the position of Chairman for Light Sciences Oncology, Inc., Finance Director for Novo Nordisk A, Investment Director at SLS Invest ApS, Managing Partner at Nordic Eye Invest ApS, Chairman at PreciSense A, Chief Executive Officer at Symphogen A, Senior Partner at Scandinavian Life Science Ventures AB, Senior Investment Manager at Scandinavian Life Science Invest ApS and Principal at PricewaterhouseCoopers (Denmark).
He received an MBA from Scandinavian International Management Institute, a graduate degree from Copenhagen Business School and an undergraduate degree from Zealand Business College.